Updated time line According to the clinical trial website the estimated completion date for the phase 1 trial was March 2022.
https://clinicaltrials.gov/ct2/show/NCT04706962
Now we know part 1 should likely be completed by March 2022. Almost 1 year after they started. Part 2 will involve more patients so we can assume it will take as long or more likely longer than part 1. So now we are looking at least March 2023 to finish the phase 1 trial which means the trial is already a year behind schedule!